Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-centre, Multi-national, Prospective, Randomised, Open-label, Comparison of Bivalirudin to Other Guideline Based Current Therapies (Excluding Bivalirudin)

NCT01087723 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT01087723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01087723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-centre, Multi-national, Prospective, Randomised, Open-label, Comparison of Bivalirudin to Other Guideline Based Current Therapies (Excluding Bivalirudin)
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
August 31, 2014
Enrollment
2,198 (actual)
Sites
145

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome